Clinical characteristics associated with bone mineral density improvement after 1-year alendronate/vitamin d(3) or calcitriol treatment: Exploratory results from a phase 3, randomized, controlled trial on postmenopausal osteoporotic women in China

Baseline and on-treatment characteristics, including age, obesity, calcium intake, and bone turnover markers, may predict the bone mineral density (BMD) response in women with postmenopausal osteoporosis (PMO) to 1 to 2 years of antiresorptive therapy and/or vitamin D supplementation. This study aim...

Descripción completa

Detalles Bibliográficos
Autores principales: Liao, Er-Yuan, Zhang, Zhen-Lin, Xia, Wei-Bo, Lin, Hua, Cheng, Qun, Wang, Li, Hao, Yong-Qiang, Chen, De-Cai, Tang, Hai, Peng, Yong-De, You, Li, He, Liang, Hu, Zhao-Heng, Song, Chun-Li, Wei, Fang, Wang, Jue, Zhang, Lei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6081166/
https://www.ncbi.nlm.nih.gov/pubmed/30075569
http://dx.doi.org/10.1097/MD.0000000000011694

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6081166/
https://www.ncbi.nlm.nih.gov/pubmed/30075569
http://dx.doi.org/10.1097/MD.0000000000011694

Ejemplares similares